Ppt1-flox Mouse
一般名
Ppt1-flox
製品ID
S-CKO-04426
背景情報
C57BL/6JCya
系統ID
CKOCMP-19063-Ppt1-B6J-VB
状況
このマウス系統を論文で使用する場合は、「Ppt1-flox Mouse(カタログ番号S-CKO-04426)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Ppt1-flox
系統ID
CKOCMP-19063-Ppt1-B6J-VB
遺伝子名
製品ID
S-CKO-04426
遺伝子別名
PPT, CLN1, INCL, D4Ertd184e, 9530043G02Rik
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 4
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000030412
NCBIトランスクリプトID
NM_008917.3
ターゲット領域
Exon 2~3
有効領域の大きさ
~1.8 kb.
遺伝子研究の概要
Palmitoyl protein thioesterase 1, is a lysosomal enzyme that catalyzes protein depalmitoylation. It is crucial in regulating lysosomes, mitochondria, lipid metabolism, and Ca2+转运, and is involved in multiple biological pathways. Dysregulation of PPT1 has been linked to various diseases, including neurological disorders and cancers [3].
In hepatocellular carcinoma (HCC), PPT1 is predominantly expressed in macrophages. High intratumoral PPT1+ macrophages abundance is associated with inferior patient survival and is an independent risk factor for prognosis. PPT1+ macrophages promote immunosuppressive transformation of the tumor microenvironment, and targeting PPT1 may enhance immunotherapy efficacy [1].
In an angiogenesis study, PPT1 -regulated depalmitoylation negatively impacts Gpx1 protein stability. Inhibiting PPT1 enhances Gpx1 palmitoylation, which suppresses angiogenesis [2].
In oral squamous cell carcinoma (OSCC), increased PPT1 expression correlates with poor prognosis, and PPT1 promotes cell proliferation, migration, invasion, and inhibits ferroptosis [4].
In a mouse model mimicking CLN1 disease (caused by inactivating mutations in PPT1), Ppt1 -deficiency dysregulates lysosomal Ca++ homeostasis, impairs lysosomal degradative function, and autophagy [5].
In melanoma, inhibiting PPT1 enhances the antitumor activity of anti -PD -1 antibody, and Ppt1 inhibition leads to M2 to M1 phenotype switching in macrophages [6].
In summary, PPT1 plays essential roles in various biological processes such as lipid metabolism, cellular homeostasis, and immune regulation. Studies using gene knockout (KO) or conditional knockout (CKO) mouse models, like in the CLN1 disease-mimicking mouse model, have been instrumental in revealing its functions in disease conditions. PPT1's involvement in diseases like HCC, OSCC, and melanoma suggests its potential as a therapeutic target for these malignancies, while its role in neurological disorders like CLN1 disease indicates its significance in understanding neurodegenerative mechanisms.
References:
1. Weng, Jialei, Liu, Shaoqing, Zhou, Qiang, Zhou, Chenhao, Ren, Ning. . Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma. In Journal for immunotherapy of cancer, 11, . doi:10.1136/jitc-2022-006655. https://pubmed.ncbi.nlm.nih.gov/37385725/
2. Ma, Yidan, Yuan, Xinxin, Wei, Aodong, Zhu, Jiangli, Kong, Eryan. 2024. Enhancing Gpx1 palmitoylation to inhibit angiogenesis by targeting PPT1. In Redox biology, 77, 103376. doi:10.1016/j.redox.2024.103376. https://pubmed.ncbi.nlm.nih.gov/39423458/
3. Zhou, Xin-Yi, Chang, Dong, Xu, Huang-Ying, Yin, Qiu-Yuan, Sun, Jian-Wei. . Progress on lysosomal PPT1-mediated regulation of cellular homeostasis and pathogenesis. In Yi chuan = Hereditas, 45, 874-886. doi:10.16288/j.yczz.23-186. https://pubmed.ncbi.nlm.nih.gov/37872111/
4. Luo, Qingqiong, Hu, Sheng, Tang, Yijie, Yang, Dandan, Chen, Qilong. . PPT1 Promotes Growth and Inhibits Ferroptosis of Oral Squamous Cell Carcinoma Cells. In Current cancer drug targets, 24, 1047-1060. doi:10.2174/0115680096294098240123104657. https://pubmed.ncbi.nlm.nih.gov/38299399/
5. Mondal, Avisek, Appu, Abhilash P, Sadhukhan, Tamal, Liu, Aiyi, Mukherjee, Anil B. 2022. Ppt1-deficiency dysregulates lysosomal Ca++ homeostasis contributing to pathogenesis in a mouse model of CLN1 disease. In Journal of inherited metabolic disease, 45, 635-656. doi:10.1002/jimd.12485. https://pubmed.ncbi.nlm.nih.gov/35150145/
6. Sharma, Gaurav, Ojha, Rani, Noguera-Ortega, Estela, Gabrilovich, Dmitry I, Amaravadi, Ravi K. 2020. PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanoma. In JCI insight, 5, . doi:10.1172/jci.insight.133225. https://pubmed.ncbi.nlm.nih.gov/32780726/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
